AULGX | VIGAX | AULGX / VIGAX | |
Total Expense Ratio | 0.69 | 0.05 | 1,380% |
Annual Report Gross Expense Ratio | 0.72 | 0.05 | 1,440% |
Fund Existence | 8 years | 25 years | - |
Gain YTD | 6.920 | 12.608 | 55% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 26.1B | 324B | 8% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 12.37 | 23.85 | 52% |
Returns for 3 years | 43.58 | 78.79 | 55% |
Returns for 5 years | 49.78 | 104.83 | 47% |
Returns for 10 years | N/A | 350.45 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CEPI | 40.59 | 0.57 | +1.43% |
Rex Crypto Equity Premium Income ETF | |||
XTL | 128.22 | 1.72 | +1.36% |
SPDR® S&P Telecom ETF | |||
AIRR | 90.51 | 0.81 | +0.90% |
First Trust RBA Amer Indl RenaisTM ETF | |||
CCRV | 20.00 | 0.03 | +0.15% |
iShares® Commodity Curve Carry Strat ETF | |||
PPH | 87.33 | -0.02 | -0.02% |
VanEck Pharmaceutical ETF |